Replagal (agalsidase alfa)

pCPA File Number: 20757
Negotiation Status:
Concluded with an LOI
Indication(s):
Fabry's Disease
Sponsor/Manufacturer:
Shire Pharma Canada ULC
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: